Cork University Hospital (CUH)
Cork, Munster, T12 DC4A, Ireland
NCT Number: NCT05259891
Children frequently present with altered or reduced consciousness levels to emergency departments. By using EEG monitoring, subclinical seizure activity may be detected, leading to earlier pharmacological intervention and improved outcomes. Post-ictal phases that may be interpreted as seizure activity may become less over-treated. A feasibility study will ascertain if EEG monitoring can be applied successfully in this cohort, within a specified time period, obtaining minimum artefact (defined as < 25% artefact). EEG recordings will not be used to guide clinical management during this feasibility study.
Looking for future studies?
Notify Me0 month–176 month
All sexes
Observational
Cork, Munster, T12 DC4A, Ireland
See study protocol attached
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Children between 0 and 15 years and 11 months who present to Resuscitation Room, ED, CUH with a Glasgow Coma Scale (GCS) < 11 or, a reduction in baseline GCS in the case of children with significant neurodisability at baseline
Exclusion criteria
Time frame: Anticipated 12 month study period
University College Cork
Other
CAPTURE:eegCap Application in Paediatrics wiTh redUced GCS in REsus
Acronym: CAPTURE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01870024
Brain Diseases, Central Nervous System Diseases
Paris, France
View Trial DetailsNCT01796574
Brain Diseases, Central Nervous System Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT05140265
Brain Diseases, Central Nervous System Diseases
Albuquerque, New Mexico, United States
View Trial DetailsNCT07689084
Brain Diseases, Central Nervous System Diseases
Marburg, Hesse, Germany
View Trial Details